Cargando…

Heterogeneity of treatment responses in rheumatoid arthritis using group based trajectory models: secondary analysis of clinical trial data

BACKGROUND: Traditionally rheumatoid arthritis (RA) trials classify patients as responders and non-responders; they ignore the potential range of treatment responses. Group Based Trajectory Models (GBTMs) provide a more refined approach. They identify patient subgroups with similar outcome trajector...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ibrahim, Fowzia, Scott, Ian C, Scott, David L, Ayis, Salma Ahmed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518927/ https://www.ncbi.nlm.nih.gov/pubmed/37749588 http://dx.doi.org/10.1186/s41927-023-00348-5

Ejemplares similares

Psychometric properties of a new treatment expectation scale in rheumatoid arthritis: an application of item response theory
por: Ibrahim, Fowzia, et al.
Publicado: (2015)

Defining the relationship between pain intensity and disease activity in patients with rheumatoid arthritis: a secondary analysis of six studies
por: Ibrahim, Fowzia, et al.
Publicado: (2022)

Characterization of missing data patterns and mechanisms in longitudinal composite outcome trial in rheumatoid arthritis
por: Ibrahim, Fowzia, et al.
Publicado: (2022)

A systematic review of guidelines for managing rheumatoid arthritis
por: Mian, Aneela, et al.
Publicado: (2019)

A systematic review of randomised controlled trials in rheumatoid arthritis: the reporting and handling of missing data in composite outcomes
por: Ibrahim, Fowzia, et al.
Publicado: (2016)

Intensive therapy and remissions in rheumatoid arthritis: a systematic review
por: Hughes, Catherine D., et al.
Publicado: (2018)

Optimal responses in disease activity scores to treatment in rheumatoid arthritis: Is a DAS28 reduction of >1.2 sufficient?
por: Mian, Aneela N., et al.
Publicado: (2016)

Baseline predictors of remission, pain and fatigue in rheumatoid arthritis: the TITRATE trial
por: Lee, Sook Yan, et al.
Publicado: (2021)

Quantifying the Impact of Unobserved Heterogeneity on Inference from the Logistic Model
por: Ayis, Salma
Publicado: (2009)

Identification of heterogenous treatment response trajectories to anti-IL6 receptor treatment in rheumatoid arthritis
por: Blair, J. P. M., et al.
Publicado: (2020)

Changing clinical patterns in rheumatoid arthritis management over two decades: sequential observational studies
por: Mian, Aneela N, et al.
Publicado: (2016)

A large two-centre study in to rates of influenza and pneumococcal vaccination and infection burden in rheumatoid arthritis in the UK
por: Subesinghe, Sujith, et al.
Publicado: (2016)

Real world long-term impact of intensive treatment on disease activity, disability and health-related quality of life in rheumatoid arthritis
por: Gullick, Nicola J., et al.
Publicado: (2019)

Mental health, fatigue and function are associated with increased risk of disease flare following TNF inhibitor tapering in patients with rheumatoid arthritis: an exploratory analysis of data from the Optimizing TNF Tapering in RA (OPTTIRA) trial
por: Bechman, Katie, et al.
Publicado: (2018)

Does intensive management improve remission rates in patients with intermediate rheumatoid arthritis? (the TITRATE trial): study protocol for a randomised controlled trial
por: Martin, Naomi H., et al.
Publicado: (2017)

The clinical effectiveness of intensive management in moderate established rheumatoid arthritis: The titrate trial
por: Scott, David, et al.
Publicado: (2020)

Disease activity trajectories for early and established rheumatoid arthritis: Real-world data from a rheumatoid arthritis cohort
por: Movahedi, Mohammad, et al.
Publicado: (2022)

Help-seeking trajectory in patients with rheumatoid arthritis
por: Pelaez, Ingris, et al.
Publicado: (2015)

Optimizing treatment with tumour necrosis factor inhibitors in rheumatoid arthritis—a proof of principle and exploratory trial: is dose tapering practical in good responders?
por: Ibrahim, Fowzia, et al.
Publicado: (2017)

Similar risk of cardiovascular events in idiopathic inflammatory myopathy and rheumatoid arthritis in the first 5 years after diagnosis
por: Párraga Prieto, Cristina, et al.
Publicado: (2020)

Identification and Prediction of Fatigue Trajectories in People With Rheumatoid Arthritis
por: Pettersson, Susanne, et al.
Publicado: (2021)

ACPA-positive and ACPA-negative rheumatoid arthritis differ in their requirements for combination DMARDs and corticosteroids: secondary analysis of a randomized controlled trial
por: Seegobin, Seth D, et al.
Publicado: (2014)

Drivers of heterogeneity in synovial fibroblasts in rheumatoid arthritis
por: Smith, Melanie H., et al.
Publicado: (2023)

Tumour necrosis factor inhibitors versus combination intensive therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis: TACIT non-inferiority randomised controlled trial
por: Scott, David L, et al.
Publicado: (2015)

Symptoms of depression and anxiety predict treatment response and long-term physical health outcomes in rheumatoid arthritis: secondary analysis of a randomized controlled trial
por: Matcham, Faith, et al.
Publicado: (2016)

Lung function trajectory of rheumatoid arthritis–associated interstitial lung disease
por: Chang, Sung Hae, et al.
Publicado: (2023)

Review of Biosimilar Trials and Data on Adalimumab in Rheumatoid Arthritis
por: Zhao, Sizheng, et al.
Publicado: (2018)

Review of Biosimilar Trials and Data on Etanercept in Rheumatoid Arthritis
por: Chadwick, Laura, et al.
Publicado: (2018)

Trajectories of Depressive Symptoms Among Older Adults and in Adults With Hip Fracture: Analysis From the English Longitudinal Study of Ageing
por: Milton-Cole, Rhian, et al.
Publicado: (2022)

Tocilizumab: A Review in Rheumatoid Arthritis
por: Scott, Lesley J.
Publicado: (2017)

Depression and the risk of rheumatoid arthritis
por: Vallerand, Isabelle A., et al.
Publicado: (2019)

Recurrent and refractory corneal perforation secondary to rheumatoid arthritis treated with infliximab
por: Al Saleh, Ahmed, et al.
Publicado: (2021)

Analysis of IGH allele content in a sample group of rheumatoid arthritis patients demonstrates unrevealed population heterogeneity
por: Hardt, Uta, et al.
Publicado: (2023)

Durability of Response to Tocilizumab Therapy in Rheumatoid Arthritis: Data from the US-Based Corrona Rheumatoid Arthritis Registry
por: Pappas, Dimitrios A., et al.
Publicado: (2021)

Asthma and the Risk of Rheumatoid Arthritis: An Insight into the Heterogeneity and Phenotypes of Asthma
por: Rolfes, Mary Claire, et al.
Publicado: (2017)

Molecular and Cellular Heterogeneity in Rheumatoid Arthritis: Mechanisms and Clinical Implications
por: Zhao, Jianan, et al.
Publicado: (2021)

The heart in rheumatoid arthritis (rheumatoid disease)--an echocardiographic study.
por: Dinsmore, W. W., et al.
Publicado: (1983)

Amyloid Goiter Associated with Amyloidosis Secondary to Rheumatoid Arthritis
por: Uzum, Gungor, et al.
Publicado: (2013)

Rituximab Therapy in Renal Amyloidosis Secondary to Rheumatoid Arthritis
por: Kilic, Levent, et al.
Publicado: (2018)

Postinfantile Giant Cell Hepatitis Secondary to Rheumatoid Arthritis
por: Martinez-Moad, Miranda, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mpsqneridohpebgcngqqom8n0e